Summary:
A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficacy and safety of investigational product compared to placebo in adult patients with active rotator cuff tendinopathy.
Qualified Participants Must:
• Be willing and able to do MRI
• Male and non-pregnant, non nursing females between 18-65 years old
• Have rotator cuff tendinopathy for between 6 weeks and 6 months
• Have nocturnal pain in shoulder on at least 3 out of 7 nights.
• No previous surgery, or plans for surgery on the affected shoulder.
• No injections of corticosteroids into shoulder in last 12 weeks
• No injections of platelet rich plasmas into shoulder in last 12 months
Qualified Participants May Receive:
Compensation for time and travel.